Forum

Case-Based Debate: In Patient with Pure T2 UC, PDL1-high, GFR 60 do I need Neoadjuvant Therapy?

Moderator(s)

• 

  Siamak Daneshmand, MD

  Professor of Urology, Director of Urologic Oncology
  University of Southern California/Norris Comphrensive Cancer Center

Debater-Pro(s)

• 

  Shilpa Gupta, MD

  Director, Genitourinary Oncology
  Cleveland Clinic Foundation

Debater-Con(s)

• 

  Arlene O. Siefker-Radtke, MD

  MD Anderson Cancer Center